Skip to main content
. Author manuscript; available in PMC: 2023 Apr 27.
Published in final edited form as: ACS Nano. 2021 Aug 6;15(10):15741–15753. doi: 10.1021/acsnano.0c09553

Figure 4.

Figure 4.

In vivo distribution of intravenously injected T-ARV-NPs in the brain, liver, and blood of female Balb/c mice for (A) EFV and T-EFV-NP, (B) EVG and T-EVG-NP, and (C) DRV and T-DRV-NP. (D) Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in the blood plasma. The animals were dosed with 40 mg/kg with respect to the ARVs.